SV40 early region oncoproteins \nand human cell transformation
Year: 2003
Type: article
Abstract: We now understand neoplastic \ntransformation to be the consequence of multiple \nacquired genetic alterations. The combination of these \nacquired changes confer the various phenotypes that \nconstitute the clinical features of cancer. Although only \nrare human cancers derive from a viral etiology, the \nstudy of DNA tumor viruses that transform rodent and \nhuman cells has led to a greater understanding of the \nmolecular events that program the malignant state. In \nparticular, investigation of the viral oncoproteins \nspecified by the Simian Virus 40 Early Region (SV40 \nER) has revealed critical host cell pathways, whose \nperturbation play an essential role in the experimental \ntransformation of mammalian cells. Recent work has reinvestigated \nthe roles of two SV40 ER oncoproteins, the \nlarge T antigen (LT) and the small t antigen (ST), in \nhuman cell transformation. Co-expression of these two \noncoproteins, together with the telomerase catalytic \nsubunit, hTERT, and an oncogenic version of the H-Ras \noncoprotein, suffices to transform human cells. LT \ninactivates two key tumor suppressor pathways by \nbinding to the retinoblastoma protein (pRB) and p53. \nThe ability of ST to transform human cells requires \ninteractions with PP2A, an abundant family of serinethreonine \nphosphatases. Here we review recent \ndevelopments in our understanding of how these two \nviral oncoproteins facilitate human cell transformation.
Authors: Chen, W., Hahn, W.C.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: New Models of Human Cancer
OpenAlex ID: W7043770193
